CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

“Clustered Regularly Interspaced Short Palindromic Repeats” or “CRISPR” doesn’t sound very impressive, but don’t be fooled. CRISPR (pronounced “crisper”) is a powerful tool that ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...